Tumor burden influences cytotoxic T cell development in metastatic breast cancer patients--a phase I/II study.

SE, Wright; KA, Rewers-Felkins; IS, Quinlin; CA, Phillips; M, Townsend; R, Philip; P, Zorsky; P, Klug; L, Dai; M, Hussain; AA, Thomas; C, Sundaramurthy

doi:10.3109/08820130903278089

Public

Tumor burden influences cytotoxic T cell development in metastatic breast cancer patients--a phase I/II study.

Shared by NobleBlocks on Jan 1, 2009 • 12:00 AM UTC

Authors:

Wright SE

Rewers-Felkins KA

Quinlin IS

Abstract

The influence of tumor burden on the generation of tumor antigen-specific cytotoxic T-lymphocytes (CTL) was investigated in a phase I/II clinical adoptive immunotherapy trial. Four previously treated metastatic breast cancer patients, two with macroscopic disease and two with no evidence of disease,...

Discussions